Byonyks
Hassan Abrar, PMP, serves as the Chief Operating Officer at Byonyks, a medical devices company, since April 2021, where responsibilities include overseeing daily operations, developing business strategies, and ensuring compliance with regulatory requirements. Prior to this, Hassan held several managerial positions at GAM Corp. Pvt. Ltd. (McDonald's Pakistan) from December 2007 to April 2021, progressing from Equipment/M&R Manager to National Manager, focusing on technical expertise in equipment procurement and project management. Earlier experience includes roles at Lucky Plastic Industries, HMA Pumps, and Ibrahim Fibres Ltd., emphasizing mechanical engineering and maintenance. Hassan holds a Bachelor's Degree in Mechanical Engineering from the University of Engineering and Technology, Lahore, completed in 2004. Key achievements include streamlining warehouse inventories and successfully implementing operational strategies across various companies.
Previous companies
This person is not in any teams
This person is not in any offices
Byonyks
Byonyks has pioneered the world’s first affordable Bloodless Dialysis machine, transforming care for kidney failure patients. Globally, over eight million people with kidney disease lack dialysis access—a costly, invasive, and time-consuming treatment that filters blood when kidneys fail. Many of these individuals face life-threatening consequences due to the lack of proper care. Byonyks addresses this critical issue with its Bloodless Dialysis machine; a safe, effective, portable, and non-invasive solution that’s more affordable than existing options. Our technology empowers patients to perform dialysis at home, overnight, while they sleep, allowing them to maintain their daily work and family responsibilities. The needle-free approach also reduces the risk of chronic infections such as HIV and Hepatitis C. Headquartered in the USA and South Asia, Byonyks is a medical device startup founded by Harvard/MIT graduates and industry experts. Our core team’s expertise contributes to over half of the operational peritoneal dialysis machines worldwide. The groundbreaking Bloodless Dialysis machine has saved multiple lives in South Asia and is currently under FDA review—a pivotal step towards making accessible kidney care a global reality.